Purpose of the Test
- Estimating the probability of epithelial ovarian cancer in women with a pelvic mass.
- Differentiating between benign and malignant tumors with high accuracy.
- Providing clinical data to guide surgical or therapeutic management.
Ensure peace of mind with the ROMA Index, a sophisticated diagnostic tool combining HE4 and CA-125 levels to accurately assess ovarian malignancy risk and support early detection for better outcomes.
Scientific name: ROMA Index (HE4 and CA-125) Calculation
A blood test calculating the probability of ovarian cancer by combining HE4 and CA-125 markers with menopausal status, providing a comprehensive risk assessment for pelvic masses.